<i>BRCA1</i> Suppresses Epithelial-to-Mesenchymal Transition and Stem Cell Dedifferentiation during Mammary and Tumor Development
Feng Bai(Shanxi Medical University), Xin‐Hai Pei(Chinese Academy of Medical Sciences & Peking Union Medical College), Ho Lam Chan(University of Miami), Anthony J. Capobianco(General Motors (Poland)), Charles M. Perou(University of North Carolina at Chapel Hill), Alan S. Livingstone(University of Miami), David J. Robbins(Georgetown University), Jason I. Herschkowitz(Baylor College of Medicine), Alexandria Scott(Stowers Institute for Medical Research), Cheng Fan(University of North Carolina at Chapel Hill), Matthew D. Smith(University of North Carolina at Chapel Hill)
Cited by 89
Related Papers
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
|The Lancet|2014|4.7k
Immunohistochemical and Clinical Characterization of the Basal-Like Subtype of Invasive Breast Carcinoma
|Clinical Cancer Research|2004|2.7k
Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer
|Breast Cancer Research|2010|2.1k
The molecular portraits of breast tumors are conserved across microarray platforms
|BMC Genomics|2006|1.5k
Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features
|Proceedings of the National Academy of Sciences|2009|1.4k